Case-control study comparing the efficacy of a therapeutic combination containing the integrase inhibitor raltegravir (400 mg x 2) or a therapeutic combination not containing raltegravir on the reduction of proviral DNA in patients presenting with a pretreated HIV-1 infection with a detectable viral load [Etude cas-temoins comparant l'efficacite d'une combinaison therapeutique contenant l'inhibiteur de l'integrase raltegravir (400 mg x 2) ou une combinaison therapeutique ne contenant pas le raltegravir sur la diminution de l'ADN proviral chez des sujets pretraites presentant une infection par le VIH-1 avec une charge virale detectable]

Trial Profile

Case-control study comparing the efficacy of a therapeutic combination containing the integrase inhibitor raltegravir (400 mg x 2) or a therapeutic combination not containing raltegravir on the reduction of proviral DNA in patients presenting with a pretreated HIV-1 infection with a detectable viral load [Etude cas-temoins comparant l'efficacite d'une combinaison therapeutique contenant l'inhibiteur de l'integrase raltegravir (400 mg x 2) ou une combinaison therapeutique ne contenant pas le raltegravir sur la diminution de l'ADN proviral chez des sujets pretraites presentant une infection par le VIH-1 avec une charge virale detectable]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2011

At a glance

  • Drugs Raltegravir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms IN-DEEP
  • Most Recent Events

    • 16 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top